Published in J Mol Cell Cardiol on June 01, 1985
Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis. JACC Cardiovasc Imaging (2011) 1.60
Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol (2012) 1.29
Mitochondrial dysfunction in heart failure. Heart Fail Rev (2013) 1.02
HLA antigens in idiopathic dilated cardiomyopathy. Br Heart J (1989) 1.02
Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Invest (1994) 0.99
Idiopathic dilated cardiomyopathy. BMJ (1990) 0.97
Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart (1997) 0.95
Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis. Immunology (1990) 0.92
Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells. J Inherit Metab Dis (1987) 0.91
Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol (1991) 0.84
Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J (1995) 0.83
Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree. J Med Genet (1994) 0.82
The mitochondrial ADP/ATP carrier: functional and structural studies in the route of elucidating pathophysiological aspects. J Bioenerg Biomembr (2008) 0.82
Significance of the adenine nucleotide translocator in the pathogenesis of viral heart disease. Mol Cell Biochem (1997) 0.80
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev (2013) 0.80
Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy. Stem Cells Int (2013) 0.80
Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev (2013) 0.80
Infectious tolerance to ADP/ATP carrier peptides induced by anti-L3T4 monoclonal antibody in dilated cardiomyopathy mice. J Clin Immunol (2005) 0.79
Identification of an Epitope from Adenine Nucleotide Translocator 1 That Induces Inflammation in Heart in A/J Mice. Am J Pathol (2016) 0.77
Analysis of mitochondrial antigens reveals inner membrane succinate dehydrogenase flavoprotein subunit as autoantigen to antibodies in anti-M7 sera. Clin Exp Immunol (2002) 0.77
Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure. Heart Vessels (2010) 0.77
Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J (2000) 2.52
Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation (1999) 2.03
[Prospective study of the incidence, pathogenesis and therapy of spontaneous, by coronary angiography diagnosed coronary artery dissection]. Z Kardiol (1998) 1.77
Biglycan is required for adaptive remodeling after myocardial infarction. Circulation (2008) 1.72
Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol (1997) 1.65
Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther (1999) 1.62
Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest (2001) 1.49
[Recurrent immune thrombocytopenia: a rare complication after contrast medium injection]. Dtsch Med Wochenschr (1995) 1.46
[New concepts in the diagnosis of inflammatory myocardial disease]. Dtsch Med Wochenschr (1997) 1.41
Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med (1997) 1.32
Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circulation (1982) 1.31
Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett (1997) 1.31
The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis. Clin Exp Immunol (1983) 1.26
Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart (1996) 1.23
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation (1999) 1.12
Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation (1999) 1.11
Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J (1989) 1.05
[Influence of insulin on membrane potentials in potassium deficiency measurements in isolated rat diaphragm]. Pflugers Arch Gesamte Physiol Menschen Tiere (1968) 1.04
Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol (2000) 1.04
Immunological results in myocardial diseases. Postgrad Med J (1978) 1.04
Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function. Circulation (1990) 1.02
Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation (1999) 1.02
Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells. Gene Ther (2000) 0.97
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res (1989) 0.94
Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Eur Heart J (1994) 0.94
Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. J Hypertens (2000) 0.94
Transcription of the adenine nucleotide translocase isoforms in various types of tissues in the rat. Biochim Biophys Acta (1999) 0.93
Determinants of short-period heart rate variability in the general population. Cardiology (2001) 0.92
[Indirect immunofluorescence test and indirect antiglobulin consumption test in diagnosis of primary cardiomyopathies]. Verh Dtsch Ges Inn Med (1973) 0.92
Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis. J Mol Cell Cardiol (2012) 0.91
Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testing. J Am Coll Cardiol (2000) 0.91
Late prosthetic valve endocarditis. Eur Heart J (1995) 0.91
Immunochemical characterization of the adenine nucleotide translocator. Organ specificity and conformation specificity. Eur J Biochem (1984) 0.90
The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy. Adv Myocardiol (1985) 0.89
[Membrane potentials of a single skeletal muscle cell in hypokalemic periodic muscle paralysis]. Klin Wochenschr (1966) 0.89
Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemost (2009) 0.89
Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol (1994) 0.89
[Current views on the clinical diagnosis of cardiomyopathy due to alcoholism]. Verh Dtsch Ges Inn Med (1974) 0.89
Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation. Cardiovasc Res (1998) 0.88
Treatment of chronic myocarditis with corticosteroids. Eur Heart J (1995) 0.88
Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter. Circulation (2000) 0.88
Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Cardiovasc Res (1999) 0.87
The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol (1996) 0.87
Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology (1994) 0.87
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Am J Cardiol (2000) 0.87
[Alcoholic Cardiomyopathy (author's transl)]. MMW Munch Med Wochenschr (1976) 0.86
[Diagnostic value of the indirect immunofluorescence test for the demonstration of humoral antibodies against the myocardium]. Internist (Berl) (1975) 0.86
The ADP/ATP carrier as a mitochondrial auto-antigen--facts and perspectives. Ann N Y Acad Sci (1986) 0.86
[Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy]. Z Kardiol (1998) 0.86
Immunohistochemistry in dilated cardiomyopathy. Eur Heart J (1995) 0.85
Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis--evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis. J Am Coll Cardiol (1998) 0.84
The shift in the myocardial adenine nucleotide translocator isoform expression pattern is associated with an enteroviral infection in the absence of an active T-cell dependent immune response in human inflammatory heart disease. J Am Coll Cardiol (2000) 0.84
Inhibition of the adenine nucleotide translocator by organ specific autoantibodies in primary biliary cirrhosis. Clin Exp Immunol (1984) 0.84
[Emergency heart valve replacement after acute cerebral embolism during florid endocarditis]. Med Klin (Munich) (1998) 0.84
Upregulation of bradykinin B1-receptor expression after myocardial infarction. Br J Pharmacol (2000) 0.84
[Membrane potentials in experimental potassium deficiency. Measurements in rat diaphragm in vitro]. Pflugers Arch Gesamte Physiol Menschen Tiere (1968) 0.83
[Acute myocardial infarct caused by a muscle bridge of the anterior interventricular ramus: complicated course with vascular perforation after stent implantation]. Z Kardiol (1997) 0.83
The (Na + + K + )-ATPase activity of guinea pig heart muscle in potassium deficiency. Arch Biochem Biophys (1971) 0.83
The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. Eur Heart J (1995) 0.83
Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia may contribute to early contractile failure. Circ Res (1994) 0.83
Methylprednisolone in chronic myocarditis. Postgrad Med J (1994) 0.83
Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function. Mol Cell Biochem (1997) 0.83
Immunoelectrophoretic characterization of the ADP/ATP carrier from heart, kidney, and liver. Arch Biochem Biophys (1985) 0.83
[Magnetcardiographic detection of abnormal intraventricular activation in patients with ischemic heart disease with and without tachycardia]. Herzschrittmacherther Elektrophysiol (1997) 0.82
Computed tomography in constrictive pericardial disease. J Comput Assist Tomogr (1981) 0.82
Roles of T cells in coxsackievirus B-induced disease. Curr Top Microbiol Immunol (1997) 0.82
[Diabetic cardiopathy: pathogenesis, diagnosis and therapy]. Internist (Berl) (2003) 0.81
Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses. Basic Res Cardiol (2014) 0.81
[Myocardial involvement in Fabry's disease (author's transl)]. Dtsch Med Wochenschr (1980) 0.81
The myocardial expression of the adenine nucleotide translocator isoforms is specifically altered in dilated cardiomyopathy. Herz (2000) 0.80
Transfer of human myocarditis into severe combined immunodeficiency mice. Circ Res (1994) 0.80
Antibodies against ADP-ATP carrier enhance Ca2+ current in isolated cardiac myocytes. Am J Physiol (1988) 0.80
The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy. Eur Heart J (1991) 0.80
Late potentials and heart rate variability in heart muscle disease. Eur Heart J (1994) 0.79
Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial. Int J Cardiol (2012) 0.79
Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion. Am J Cardiol (1999) 0.79
Acute negative inotropic effect of adriamycin (doxorubicin). Naunyn Schmiedebergs Arch Pharmacol (1981) 0.79
Platelet activation in diabetic microangiopathy. Platelets (1998) 0.79
Chronic inflammation in the myocardium of patients with clinically suspected dilated cardiomyopathy. J Card Fail (1994) 0.79
High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract (2008) 0.79
[Diagnostic approach and optimal treatment of aortic valve stenosis]. Herz (1998) 0.79
[Surgical angioplasty of the left main coronary artery. Evaluation and postoperative follow-up with intravascular ultrasound]. Z Kardiol (2002) 0.78
Is myocardial Na+/Ca2+ exchanger transcription a marker for different stages of myocardial dysfunction? Quantitative polymerase chain reaction of the messenger RNA in endomyocardial biopsies of patients with heart failure. J Am Coll Cardiol (2000) 0.78
[Myocarditis and dilated cardiomyopathy. New methods in diagnosis and therapy]. MMW Fortschr Med (2002) 0.78
Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes. J Am Coll Cardiol (1997) 0.78
Impairment of myocardial calcium homeostasis by antibodies against the adenine nucleotide translocator. Cell Calcium (1999) 0.78
[Antimyosin scintigraphy for diagnosis and follow-up of patients with clinically suspected myocarditis]. Z Kardiol (1998) 0.78
[Optimal management of primary and secondary mitral regurgitation]. Herz (1998) 0.77
[Non-surgical management of a perforated left anterior descending coronary artery following cardiopulmonary resuscitation]. Z Kardiol (1999) 0.77
[Cardiac effects of antikaliuretic diuretics-clinical and biochemical investigation (author's transl)]. Klin Wochenschr (1977) 0.77
Platelet activation in diabetic cardiovascular autonomic neuropathy. Diabet Med (1999) 0.77
[Coronary disease. II. Analysis of diastolic pressure-volume correlations and left ventricular elasticity in 110 patients]. Z Kardiol (1975) 0.77
[ Update 2001. Myocarditis--cardiomyopathy]. Med Klin (Munich) (2001) 0.77
Intracardiac thrombosis: patient-related and device-related factors. J Heart Valve Dis (1995) 0.77
Impairment of left ventricular function in combined immune deficiency mice after transfer of peripheral blood leukocytes from patients with myocarditis. Eur Heart J (1995) 0.77